BioCentury
ARTICLE | Clinical News

FDA grants TLC178 rare pediatric disease designation

May 4, 2017 4:05 PM UTC

FDA granted rare pediatric disease designation to TLC178 from Taiwan Liposome Co. Ltd. (TPEx:4152) to treat rhabdomyosarcoma. The liposomal encapsulated formulation of vinorelbine has Orphan Drug des...

BCIQ Company Profiles

Taiwan Liposome Co. Ltd.

BCIQ Target Profiles

Tubulin